Literature DB >> 3493139

Cerebral and cerebellar uptake of 99mTc-(d,1)-hexamethyl-propyleneamine oxime (HM-PAO) in patients with brain tumor studied by single photon emission computerized tomography.

M W Lindegaard, A Skretting, B Hager, K Watne, K F Lindegaard.   

Abstract

The cerebral and cerebellar distribution of 99mTc-(d,1)-hexamethylpropyleneamine oxime (HM-PAO) was investigated by means of a rotating gamma camera in 12 patients with cerebral glioma. Using the corresponding contralateral region as control, reduced uptake of HM-PAO in the tumor region was demonstrated in 10 of the 12 patients. Reduced blood flow in a brain area remote from a circumscribed lesion reflects reduced activation following the interruption of afferent nervous pathways. Reduced HM-PAO uptake indicative of such diaschisis was demonstrated in the visual cortex contralateral to homonymous hemianopia in the two patients with this deficit. In the three patients with the most marked hemiparesis, the cerebellar hemisphere contralateral to the tumor showed significantly reduced HM-PAO uptake indicative of crossed cerebellar diaschisis. SPECT using commonly available gamma cameras and 99mTc-HM-PAO seems capable of depicting reduced flow in functionally inactivated brain areas, and may be clinically interesting as an alternative to more specialized techniques for the investigation of local cerebral blood flow.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3493139     DOI: 10.1007/BF00254743

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  16 in total

1.  Experimental study of distant effects of acute focal brain injury; a study of diaschisis.

Authors:  W H KEMPINSKY
Journal:  AMA Arch Neurol Psychiatry       Date:  1958-04

2.  A reawakening of interest in radionuclide brain imaging.

Authors:  R A Holmes
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

3.  Regional cerebral blood flow in patients with intracranial tumors.

Authors:  R Pálvölgyi
Journal:  J Neurosurg       Date:  1969-08       Impact factor: 5.115

4.  Regional cerebral blood flow in stroke by 133Xenon inhalation and emission tomography.

Authors:  N A Lassen; L Henriksen; O Paulson
Journal:  Stroke       Date:  1981 May-Jun       Impact factor: 7.914

5.  In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.

Authors:  C G Rhodes; R J Wise; J M Gibbs; R S Frackowiak; J Hatazawa; A J Palmer; D G Thomas; T Jones
Journal:  Ann Neurol       Date:  1983-12       Impact factor: 10.422

6.  Regional cerebral blood flow in patients with transient ischemic attacks studied by Xenon-133 inhalation and emission tomography.

Authors:  S Vorstrup; R Hemmingsen; L Henriksen; H Lindewald; H C Engell; N A Lassen
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

7.  Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging.

Authors:  D P Nowotnik; L R Canning; S A Cumming; R C Harrison; B Higley; G Nechvatal; R D Pickett; I M Piper; V J Bayne; A M Forster
Journal:  Nucl Med Commun       Date:  1985-09       Impact factor: 1.690

8.  Thalamic tumours invading the brain stem produce crossed cerebellar diaschisis demonstrated by PET.

Authors:  H Fukuyama; M Kameyama; K Harada; N Fujimoto; A Kobayashi; W Taki; T Ishikawa; H Handa; S Tanada; K Torizuka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-05       Impact factor: 10.154

9.  Dynamic SPECT with Xe-133: regional cerebral blood flow in patients with unilateral cerebrovascular disease: concise communication.

Authors:  U Buell; E A Moser; P Schmiedek; G Leinsinger; T Kreisig; C M Kirsch; K Einhäupl
Journal:  J Nucl Med       Date:  1984-04       Impact factor: 10.057

10.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.

Authors:  P F Sharp; F W Smith; H G Gemmell; D Lyall; N T Evans; D Gvozdanovic; J Davidson; D A Tyrrell; R D Pickett; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

View more
  6 in total

1.  99mTc-hexamethylpropylene amine oxime SPECT and X-ray CT in acute cerebral ischaemia.

Authors:  M Feldmann; E Voth; D Dressler; T Henze; K Felgenhauer
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

2.  Evaluation of primary lung carcinoma using technetium 99m-hexamethylpropylene amine oxime: preliminary clinical experience.

Authors:  M Oshima; K Itoh; S Okae; M Tadokoro; Y Kodama; S Sakuma
Journal:  Eur J Nucl Med       Date:  1990

3.  An evaluation of 99mTc-HMPAO uptake in cerebral gliomas--a comparison with X-ray CT.

Authors:  A T Irvine; M A Flower; R J Ott; J W Babich; F Kabir; V R McCready
Journal:  Eur J Nucl Med       Date:  1990

4.  Quantitative single-photon emission tomography for tumour blood flow measurement in bronchial carcinoma.

Authors:  N P Rowell; M A Flower; B Cronin; V R McCready
Journal:  Eur J Nucl Med       Date:  1993-07

5.  Initial experience with Tc-99m-HM-PAO in the study of brain tumors.

Authors:  J W Babich; F Keeling; M A Flower; L Repetto; A Whitton; S Fielding; A Fullbrook; R J Ott; V R McCready
Journal:  Eur J Nucl Med       Date:  1988

6.  Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours.

Authors:  R A Dierckx; J J Martin; A Dobbeleir; R Crols; I Neetens; P P De Deyn
Journal:  Eur J Nucl Med       Date:  1994-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.